Multi-center, Randomized, Double-blinded Study of Teriflunomide in Radiologically Isolated Syndrome (RIS) The TERIS Study
Latest Information Update: 23 Aug 2023
At a glance
- Drugs Teriflunomide (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- Acronyms TERIS
- 12 Aug 2023 Results assessing the time to onset of symptoms consistent with MS published in the JAMA Neurology.
- 27 Apr 2023 Results assessing efficacy of teriflunomide in extending the time to a seminal acute or progressive demyelinating event in a cohort of radiologically isolated syndrome subjects from Europe and Turkiye presented at the 75th Annual Meeting of the American Academy of Neurology 2023
- 16 Mar 2023 Status changed from active, no longer recruiting to completed.